01739nam a2200409 i 45000010008000000030008000080050017000160060019000330070007000520080041000590200033001000350017001330390012001500400036001620500020001980900025002182450213002432640037004562640011004933000023005043360021005273370023005483380032005714900044006035040051006475050095006985060060007935960007008536500031008607000043008917000025009348300057009598560110010169490014011269260105011407580084012456786192FlBoTFG20150115163112.0m|||||o||d||||||||cr||||150115t20152015fluadf  ob    001 0 eng d  a9781466555471 (e-book : PDF)  aocn899003680  aexclude  aFlBoTFGbengerdacFlBoTFGdAEU 4aRS57b.Q36 2015  aInternet AccessbAEU00aQuantitative evaluation of safety in drug development :bdesign, analysis and reporting /cedited by Qi Jiang, Amgen Inc, Thousand Oaks, California, USA; H. Amy Xia, Amgen Inc, Thousand Oaks, California, USA. 1aBoca Raton :bCRC Press,c[2015] 4cÂ©2015  a1 online resource.  atext2rdacontent  acomputer2rdamedia  aonline resource2rdacarrier1 aChapman & Hall/CRC biostatistics series  aIncludes bibliographical references and index.0 asection 1. Study design -- section 2. Safety monitoring -- section 3. Evaluation/analysis.  aAccess restricted to authorized users and institutions.  a44 0aPharmaceutical arithmetic.1 aJiang, Qic(Biostatistician),eeditor.1 aXi, H. Amy,eeditor. 0aChapman & Hall/CRC biostatistics series (Unnumbered)403University of Alberta Accessuhttp://marc.crcnetbase.com/isbn/9781466555471z(Unlimited Concurrent Users)  hUAINzCRC  aInternet AccesswLCc1i6786192-1001lINTERNETmUAINTERNETrYsYtE-RESOURCEu1/20/2015xE-BOOKzCRC01ahttp://id.loc.gov/authorities/names/n2014190050bhttp://viaf.org/viaf/311463989